Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Correlation between albuminuria at the end of study and percentage variation (Δ) of vitamin D (VD).

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were guided to inform the study team if an adverse event and/or recurrent hypoglycemia (capillary blood glucose <70 mg/dL), and/or hyperglycemia (blood glucose in capillary fasting ≥240 mg/dL in two consecutive days) occurred.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Albuminuria Reduction after High Dose of Vitamin D in Patients with Type 1 Diabetes Mellitus: A Pilot Study

Study design awaiting verification · Frontiers in Endocrinology · 2017

Original publication title

Albuminuria Reduction after High Dose of Vitamin D in Patients with Type 1 Diabetes Mellitus: A Pilot Study

João Soares Felício; Alana Ferreira de Oliveira; Amanda Soares Peixoto; Ana Carolina Contente Braga de Souza; João Felício Abrahão Neto; Franciane Trindade Cunha de Melo; Carolina Tavares Carvalho; Manuela Nascimento de Lemos; Sávio Diego Nascimento Cavalcante; Fabricio de Souza Resende; Márcia Costa dos Santos; Ana Regina Motta; Luísa Corrêa Janaú; Elizabeth Sumi Yamada; Karem Miléo Felício

Copyright © 2017 Felício, Oliveira, Peixoto, Souza, Abrahão Neto, de Melo, Carvalho, Lemos, Cavalcante, Resende, Santos, Motta, Janaú, Yamada and Felício.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our pilot study suggests an association between VD high dose supplementation, lower prevalence and improvement in stages of DKD in T1DM.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Some studies suggest an association between diabetic kidney disease (DKD) and vitamin D (VD), but there is no data about the effect of high dose of VD on DKD in type 1 diabetes mellitus (T1DM). Our pilot study aims to evaluate albuminuria reduction in patients with T1DM supplemented with high dose of VD.

Source: Background

Abstract: What methods does the paper describe?

22 patients received doses of 4,000 and 10,000 IU/day of cholecalciferol for 12 weeks according to patient’s previous VD levels. They were submitted to continuous glucose monitoring system, 24 hours ambulatory blood pressure monitoring and urine albumin-to-creatinine ratio before and after VD supplementation.

Source: Methods

Abstract: Results

There was a reduction of DKD prevalence at the end of the study (68 vs 32%; p = 0.05), with no changes on insulin doses, glycated hemoglobin, glycemic variability and blood pressure values. A correlation between percentage variation of VD levels (ΔVD) and albuminuria at the end of the study was presented (r = −0.5; p < 0.05). Among T1DM patients with DKD at the beginning of the study, 8/13 (62%) had their DKD stage improved, while the other five ones (38%) showed no changes (p < 0.05).

Source: Results

Abstract: Conclusion

Our pilot study suggests an association between VD high dose supplementation, lower prevalence and improvement in stages of DKD in T1DM.

Source: Conclusion
Authors’ abstract

Background

Some studies suggest an association between diabetic kidney disease (DKD) and vitamin D (VD), but there is no data about the effect of high dose of VD on DKD in type 1 diabetes mellitus (T1DM). Our pilot study aims to evaluate albuminuria reduction in patients with T1DM supplemented with high dose of VD.

Methods

22 patients received doses of 4,000 and 10,000 IU/day of cholecalciferol for 12 weeks according to patient’s previous VD levels. They were submitted to continuous glucose monitoring system, 24 hours ambulatory blood pressure monitoring and urine albumin-to-creatinine ratio before and after VD supplementation.

Results

There was a reduction of DKD prevalence at the end of the study (68 vs 32%; p = 0.05), with no changes on insulin doses, glycated hemoglobin, glycemic variability and blood pressure values. A correlation between percentage variation of VD levels (ΔVD) and albuminuria at the end of the study was presented (r = −0.5; p < 0.05). Among T1DM patients with DKD at the beginning of the study, 8/13 (62%) had their DKD stage improved, while the other five ones (38%) showed no changes (p < 0.05).

Conclusion

Our pilot study suggests an association between VD high dose supplementation, lower prevalence and improvement in stages of DKD in T1DM.

Publication and source details

Original title: Albuminuria Reduction after High Dose of Vitamin D in Patients with Type 1 Diabetes Mellitus: A Pilot Study

João Soares Felício; Alana Ferreira de Oliveira; Amanda Soares Peixoto; Ana Carolina Contente Braga de Souza; João Felício Abrahão Neto; Franciane Trindade Cunha de Melo; Carolina Tavares Carvalho; Manuela Nascimento de Lemos; Sávio Diego Nascimento Cavalcante; Fabricio de Souza Resende; Márcia Costa dos Santos; Ana Regina Motta; Luísa Corrêa Janaú; Elizabeth Sumi Yamada; Karem Miléo Felício

Frontiers in Endocrinology · 2017

Edited by: Åke Sjöholm, Gävle Hospital, Sweden

Reviewed by: Maria K. Svensson, Uppsala University, Sweden; Hidetaka Hamasaki, Hamasaki Clinic, Japan

*Correspondence: João Soares Felício, felicio.bel@terra.com.br

Specialty section: This article was submitted to Diabetes, a section of the journal Frontiers in Endocrinology

Copyright © 2017 Felício, Oliveira, Peixoto, Souza, Abrahão Neto, de Melo, Carvalho, Lemos, Cavalcante, Resende, Santos, Motta, Janaú, Yamada and Felício.2017Felício, Oliveira, Peixoto, Souza, Abrahão Neto, de Melo, Carvalho, Lemos, Cavalcante, Resende, Santos, Motta, Janaú, Yamada and Felíciohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T21:34:41.492323+00:00

DOI: 10.3389/fendo.2017.00199 · PMC5557778